Adults with kidney disease undergoing creation of a radiocephalic fistula ( RCF ) or brachiocephalic fistula were randomized to treatment with placebo ( n = 51 ) , PRT-201 at 10 g ( n = 51 ) , or PRT-201 at 30 g ( n = 49 ) .